Patents

7.

6.

5.

4.

3.

2.

1.

Zhen Gu, Jicheng Yu, and Guojun Chen, “Microneedle-Array Patches With Glucose-Responsive Matrix For Closed-Loop Insulin Delivery”, PCT/US2019/048063, 2019 (Accepted into the U.S. Food and Drug Administration's “Emerging Technology Program”)

 

Shaoqin Gong, Kris Saha, Guojun Chen, Amr A. Abdeen, Yuyuan Wang, and Ruosen Xie, “Nanocapsule Delivery System for Ribonucleoproteins”, UA Patent, 16/113,963, 2021 (Granted)

 

Shaoqin Gong, and Guojun Chen, “Unimolecular Nanoparticles for Efficient Delivery of Therapeutic RNA”, US Patent 15/819,424, 2020 (Granted)


Craig C. Kent, Shaoqin Gong, Xudong Shi, Guojun Chen, and Lianwang Guo, “Perivascular Drug Delivery System”, US Patent 10,668,017, 2020 (Granted)

Craig K. Kent, Shaoqin Gong, Lianwang Guo, Guojun Chen, and Bowen Wang, “Biomimetic Vesicles And Uses Thereof”, PCT/US2019/033861, 2019 (Pending).

Richard E. Wirz, Zhen Gu, Zhitong Chen, and Guojun Chen, "Methods For Treating Cancers and Tumors with Cold Atmospheric Plasma Delivery", U.S. Serial No. 63/197,258, 2021 (Pending)


Zhen Gu, Richard E. Wirz, Guojun Chen, and Zhitong Chen, “Transdermal Microneedle-Mediated Immune Checkpoint Blockade Therapy”, PCT/ US20/064361, 2020 (Pending).